Exoskeleton Market by Component (Sensors, Actuators, Power Systems, Controllers, Software), Functionality (Assistive, Rehabilitative, Augmentative, Preventive), Type (Powered, Passive, Hybrid), Body Part (Lower, Upper, Full Body) - Global Forecast to 2030

May 2025 | 255 pages | ID: E4ACD6D3D3D6EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period. Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors.

“Powered exoskeleton segment to register the highest CAGR during the forecast period.”

The market for powered exoskeletons is experiencing accelerated growth, fueled by significant funding activities that underscore rising investor confidence and commercialization potential. For instance, in December 2023, German Bionic, a developer of electrically powered exoskeletons, secured more than USD 16.3 million in an expanded Series A funding round. This funding is aimed at strengthening the company’s collaboration with its industrialization partner, Mubea, to scale production and improve deployment capabilities. In the same month, Verve Motion, a Cambridge-based startup specializing in robotic exosuits designed to enhance the physical capabilities of workers in demanding roles, successfully raised USD 20 million in a Series B funding round. These developments reflect a broader trend of strategic investments in powered exoskeleton technologies, positioning them as viable solutions for industrial automation, injury prevention, and workforce augmentation across various sectors.

“Industrial vertical to register the second-highest CAGR during the forecast period.”

The industrial sector is rapidly emerging as a significant adopter of exoskeleton technology, driven by the need to improve worker safety, reduce fatigue, and increase productivity in labor-intensive environments. Exoskeletons are particularly useful in industries such as manufacturing, warehousing, logistics, and assembly lines, where workers often perform repetitive lifting, bending, and overhead tasks. By supporting the lower back, shoulders, and legs, these wearable devices help reduce the risk of musculoskeletal injuries, one of the most common causes of lost workdays and rising occupational health costs.

“Germany to dominate European exoskeleton market.”

Germany represents one of the most advanced and mature markets for exoskeleton technology in Europe, driven by strong industrial demand, innovation in healthcare, and significant private investments. The country’s robust manufacturing and logistics sectors are actively adopting exoskeletons to improve workforce efficiency and reduce musculoskeletal injuries. German Bionic, a leading domestic developer, exemplifies this trend. In December 2023, the company raised over USD 16.3 million in an expanded Series A funding round to advance its product portfolio. Its exoskeletons, Apogee and Apogee+, are used in logistics, retail, and healthcare settings to assist with lifting, walking, and posture correction. These connected wearables are helping redefine workplace ergonomics across Germany’s key industries.
  • By Company Type: Tier 1 – 25%, Tier 2 – 40%, and Tier 3 – 35%
  • By Designation: C-level Executives – 30%, Directors – 28%, and Others – 42%
  • By Region: North America– 43%, Europe – 15%, Asia Pacific– 37%, and RoW- 05%
Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market.

The study includes an in-depth competitive analysis of these key players in the exoskeleton market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the exoskeleton market by component (hardware, software), type (powered, passive, hybrid), body part (lower extremities, upper extremities, full body), structure (rigid, soft), mobility (stationary, mobile), vertical (healthcare, defense, industrial, construction, other verticals), and region (North America, Europe, Asia Pacific, and RoW). The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the exoskeleton market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies (contracts, partnerships, agreements, new product launches, mergers & acquisitions); and recent developments associated with the exoskeleton market. This report covers the competitive analysis of upcoming startups in the exoskeleton market ecosystem.

Reasons to Buy This Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall exoskeleton market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
  • Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market
  • Market Development: Comprehensive information about lucrative markets – the report analyses the exoskeleton market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
  1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  1.3.2 YEARS CONSIDERED
  1.3.3 INCLUSIONS AND EXCLUSIONS
1.4 CURRENCY CONSIDERED
1.5 UNITS CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 List of major secondary sources
    2.1.1.2 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Intended participants and key opinion leaders in primary interviews
    2.1.2.2 List of major participants in primary interviews
    2.1.2.3 Key data from primary sources
    2.1.2.4 Breakdown of primary interviews
  2.1.3 SECONDARY AND PRIMARY RESEARCH
    2.1.3.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
    2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side)
  2.2.2 TOP-DOWN APPROACH
    2.2.2.1 Approach to arrive at market size using top-down analysis (supply side)
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EXOSKELETON MARKET
4.2 EXOSKELETON MARKET IN NORTH AMERICA, BY COUNTRY AND VERTICAL
4.3 EXOSKELETON MARKET IN ASIA PACIFIC, BY VERTICAL
4.4 EXOSKELETON MARKET, BY COUNTRY

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Rising demand for robotic rehabilitation solutions from healthcare sector
    5.2.1.2 Increased adoption in industrial and manufacturing sectors
    5.2.1.3 Increased FDA approvals for medical exoskeletons
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of ownership
  5.2.3 OPPORTUNITIES
    5.2.3.1 Integration of exoskeletons with AI and IoT technologies
    5.2.3.2 Increasing adoption of exoskeletons in military and defense sectors
  5.2.4 CHALLENGES
    5.2.4.1 Comfort and movement interference for workers
    5.2.4.2 Power supply limitations and operational downtime
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.6 PRICING ANALYSIS
  5.6.1 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024
  5.6.2 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024
  5.6.3 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022–2024
  5.6.4 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022–2024
5.7 TECHNOLOGY ANALYSIS
  5.7.1 KEY TECHNOLOGIES
    5.7.1.1 Actuators and motors
    5.7.1.2 Sensors and feedback systems
  5.7.2 COMPLEMENTARY TECHNOLOGIES
    5.7.2.1 IoT connectivity
    5.7.2.2 AI and ML
  5.7.3 ADJACENT TECHNOLOGIES
    5.7.3.1 Artificial muscles
    5.7.3.2 Physical therapy equipment
5.8 PORTER'S FIVE FORCES ANALYSIS
  5.8.1 INTENSITY OF COMPETITIVE RIVALRY
  5.8.2 BARGAINING POWER OF SUPPLIERS
  5.8.3 BARGAINING POWER OF BUYERS
  5.8.4 THREAT OF SUBSTITUTES
  5.8.5 THREAT OF NEW ENTRANTS
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
  5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  5.9.2 BUYING CRITERIA
5.10 CASE STUDY ANALYSIS
  5.10.1 ENHANCING WORKER ERGONOMICS AND PRODUCTIVITY AT JOHN DEERE WITH COMAU’S MATE-XT WEARABLE EXOSKELETON
  5.10.2 ENHANCING LOGISTICS OPERATIONS AND WORKER WELL-BEING AT FIEGE GROUP WITH GERMAN BIONIC AI-POWERED EXOSKELETON TECHNOLOGY
  5.10.3 ENHANCING WORKER SAFETY AND PRODUCTIVITY IN TUNNEL CONSTRUCTION AT GRANITE CONSTRUCTION WITH LEVITATE TECHNOLOGIES EXOSKELETONS
  5.10.4 REDUCING PHYSICAL STRAIN IN TRUCK MAINTENANCE AT MAN TRUCK & BUS WITH HELP OF SUITX TECHNOLOGY BY OTTOBOCK
  5.10.5 FORD MOTOR COMPANY ENHANCES WORKER SAFETY AND REDUCES INJURIES WITH EKSO BIONICS EKSOVEST
5.11 INVESTMENT AND FUNDING SCENARIO
5.12 TRADE ANALYSIS, 2020–2024
  5.12.1 IMPORT SCENARIO (HS CODE 9021)
  5.12.2 EXPORT SCENARIO (HS CODE 9021)
5.13 PATENT ANALYSIS
5.14 KEY CONFERENCES AND EVENTS, 2025–2026
5.15 TARIFF AND REGULATORY LANDSCAPE
  5.15.1 TARIFF ANALYSIS, 2024
  5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  5.15.3 STANDARDS
5.16 IMPACT OF AI ON EXOSKELETON MARKET
  5.16.1 INTRODUCTION
  5.16.2 AI-SPECIFIC USE CASES
5.17 2025 US TARIFF IMPACT ON EXOSKELETON MARKET
  5.17.1 INTRODUCTION
  5.17.2 KEY TARIFF RATES
  5.17.3 PRICE IMPACT ANALYSIS
  5.17.4 KEY IMPACTS ON VARIOUS COUNTRIES/REGIONS
    5.17.4.1 US
    5.17.4.2 Europe
    5.17.4.3 Asia Pacific
  5.17.5 END-USE INDUSTRY IMPACT

6 EXOSKELETON MARKET, BY MATERIAL

6.1 INTRODUCTION
6.2 CARBON FIBER
  6.2.1 GROWING EMPHASIS ON LIGHTWEIGHT MATERIALS IN WEARABLE ROBOTICS TO DRIVE MARKET
6.3 METAL
  6.3.1 HIGH STRUCTURAL STRENGTH AND LOAD-BEARING CAPACITY TO DRIVE DEMAND
6.4 STEEL ALLOYS
  6.4.1 SUPERIOR DURABILITY IN HARSH WORK ENVIRONMENTS TO DRIVE MARKET
6.5 ALUMINUM
  6.5.1 CORROSION RESISTANCE AND LIGHTWEIGHT DESIGN TO FUEL SEGMENT GROWTH

7 EXOSKELETON MARKET, BY STRUCTURE

7.1 INTRODUCTION
7.2 RIGID EXOSKELETONS
  7.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
7.3 SOFT EXOSKELETONS
  7.3.1 INCREASING STARTUP FUNDING AND EXPANDING USE IN PERSONAL STRUCTURE TO DRIVE MARKET

8 EXOSKELETON MARKET, BY MOBILITY

8.1 INTRODUCTION
8.2 STATIONARY
  8.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
8.3 MOBILE
  8.3.1 RISING STARTUP FUNDING AND EXPANDING USE IN PERSONAL MOBILITY TO DRIVE MARKET

9 EXOSKELETON MARKET, BY BODY PART

9.1 INTRODUCTION
9.2 LOWER EXTREMITIES
  9.2.1 RISING PREVALENCE OF SPINAL CORD INJURIES TO BOOST MARKET DEMAND
9.3 UPPER EXTREMITIES
  9.3.1 ADVANCEMENTS IN PASSIVE AND LIGHTWEIGHT EXOSKELETONS TO DRIVE MARKET
9.4 FULL BODY
  9.4.1 ADOPTION IN COMPLEX REHABILITATION PROGRAMS AND RISING USE IN HEAVY INDUSTRIAL APPLICATIONS TO FUEL DEMAND

10 EXOSKELETON MARKET, BY COMPONENT

10.1 INTRODUCTION
10.2 SENSORS
  10.2.1 INTEGRATION OF AI AND ML TO BOOST DEMAND
  10.2.2 GYROSCOPES
  10.2.3 ACCELEROMETERS
  10.2.4 TILT SENSORS
  10.2.5 FORCE/TORQUE SENSORS
  10.2.6 POSITION SENSORS
  10.2.7 ELECTROMYOGRAPHY SENSORS
10.3 ACTUATORS
  10.3.1 COMPATIBILITY WITH ADVANCED CONTROLLERS AND SENSORS FOR REAL-TIME MOTION COORDINATION TO DRIVE MARKET
10.4 POWER SOURCES
  10.4.1 ADVANCEMENTS IN BATTERY TECHNOLOGIES TO BOOST MARKET
10.5 CONTROL SYSTEMS
  10.5.1 ADVANCEMENTS IN ML AND REAL-TIME DATA PROCESSING TO DRIVE MARKET
10.6 OTHER COMPONENTS

11 EXOSKELETON MARKET, BY TYPE

11.1 INTRODUCTION
11.2 POWERED EXOSKELETON
  11.2.1 RISING ADOPTION OF ROBOTIC ASSISTANCE IN REHABILITATION AND MOBILITY SUPPORT FOR PATIENTS TO FUEL MARKET GROWTH
  11.2.2 POWERED EXOSKELETONS, BY TECHNOLOGY
    11.2.2.1 Advancements in battery technology and energy-efficient actuators to fuel market growth
    11.2.2.2 Electric
    11.2.2.3 Pneumatic
    11.2.2.4 Hydraulic
11.3 PASSIVE EXOSKELETON
  11.3.1 INCREASING FOCUS ON WORKPLACE ERGONOMICS AND INJURY PREVENTION TO FUEL ADOPTION

12 EXOSKELETON MARKET, BY VERTICAL

12.1 INTRODUCTION
12.2 HEALTHCARE
  12.2.1 RISING FDA CLEARANCE AND STARTUP FUNDING TO FUEL GROWTH OF MEDICAL EXOSKELETONS SEGMENT
  12.2.2 REHABILITATION
  12.2.3 DISABILITY ASSISTANCE
  12.2.4 ELDERLY CARE
12.3 DEFENSE
  12.3.1 INCREASING DEMAND FOR ENHANCED SOLDIER PERFORMANCE AND OPERATIONAL EFFICIENCY TO COMPLEMENT MARKET GROWTH
  12.3.2 ENHANCED MOBILITY
  12.3.3 INJURY PREVENTION
  12.3.4 STEALTH AND TACTICAL OPERATIONS
12.4 INDUSTRIAL
  12.4.1 INCREASED FOCUS ON WORKPLACE SAFETY AND COMPLIANCE TO DRIVE MARKET
  12.4.2 HEAVY LIFTING
  12.4.3 REPETITIVE TASK ASSISTANCE
  12.4.4 POSTURAL SUPPORT
  12.4.5 LOGISTICS
  12.4.6 MATERIAL HANDLING
12.5 CONSTRUCTION
  12.5.1 INCREASING FOCUS ON WORKER HEALTH TO FUEL ADOPTION OF EXOSKELETONS
  12.5.2 LIFTING ASSISTANCE
  12.5.3 ENHANCED PRODUCTIVITY AND EFFICIENCY
12.6 OTHER VERTICALS

13 EXOSKELETON MARKET, BY REGION

13.1 INTRODUCTION
13.2 NORTH AMERICA
  13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  13.2.2 US
    13.2.2.1 Growing military focus on injury prevention and surge in startup funding to drive market
  13.2.3 CANADA
    13.2.3.1 Government contracts supporting defense applications to boost market
  13.2.4 MEXICO
    13.2.4.1 Strategic investments in hospital infrastructure to foster revenue growth
13.3 EUROPE
  13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  13.3.2 UK
    13.3.2.1 Government support through defense innovation program to propel market
  13.3.3 GERMANY
    13.3.3.1 Presence of leading exoskeleton manufacturers and startups to complement revenue growth
  13.3.4 FRANCE
    13.3.4.1 Strong public and private investment in MedTech to boost market
  13.3.5 ITALY
    13.3.5.1 Strong collaboration between research institutes and industry to drive market
  13.3.6 POLAND
    13.3.6.1 Strategic partnerships with global exoskeleton providers to drive market
  13.3.7 NORDICS
    13.3.7.1 Academic and institutional R&D in robotics to drive market
  13.3.8 REST OF EUROPE
13.4 ASIA PACIFIC
  13.4.1 MACRO ECONOMIC OUTLOOK FOR ASIA PACIFIC
  13.4.2 CHINA
    13.4.2.1 Military investment in wearable robotics for logistics and mobility to boost market
  13.4.3 JAPAN
    13.4.3.1 Rapidly aging population and government support to create lucrative market growth opportunities
  13.4.4 SOUTH KOREA
    13.4.4.1 Advancements in lightweight, AI-integrated wearable robotics systems to drive market
  13.4.5 INDIA
    13.4.5.1 Military adoption for enhanced soldier endurance and injury prevention to boost market
  13.4.6 AUSTRALIA
    13.4.6.1 High healthcare spending to encourage adoption of advanced assistive technologies and boost demand
  13.4.7 INDONESIA
    13.4.7.1 High paraplegic population demanding affordable mobility rehabilitation solutions to drive market
  13.4.8 MALAYSIA
    13.4.8.1 Rising demand for rehabilitation devices that support patient mobility recovery to create growth opportunities
  13.4.9 THAILAND
    13.4.9.1 Government-backed research funding to boost exoskeleton technology development
  13.4.10 VIETNAM
    13.4.10.1 Increased research initiatives by domestic academic and medical institutions to drive market
  13.4.11 REST OF ASIA PACIFIC
13.5 REST OF THE WORLD
  13.5.1 MACROECONOMIC OUTLOOK FOR ROW
  13.5.2 MIDDLE EAST
    13.5.2.1 Bahrain
      13.5.2.1.1 Growing adoption of smart transportation and home automation to drive demand
    13.5.2.2 Kuwait
      13.5.2.2.1 Focus on improving healthcare accessibility and patient outcomes to fuel market
    13.5.2.3 Oman
      13.5.2.3.1 Rising prevalence of neurological and musculoskeletal disorders to drive market
    13.5.2.4 Qatar
      13.5.2.4.1 Strategic focus on defense modernization and soldier performance to increase market demand
    13.5.2.5 Saudi Arabia
      13.5.2.5.1 Vision 2030 focus on healthcare innovation and technology adoption to fuel market
    13.5.2.6 UAE
      13.5.2.6.1 Investment in R&D of intelligent robotic systems to drive market
    13.5.2.7 Rest of the Middle East
  13.5.3 SOUTH AMERICA
    13.5.3.1 Partnerships with global exoskeleton technology providers and manufacturers to support market
  13.5.4 AFRICA
  13.5.5 SOUTH AFRICA
    13.5.5.1 Focus on improving worker safety in high-risk mining operations to drive market
  13.5.6 OTHER AFRICAN COUNTRIES

14 COMPETITIVE LANDSCAPE

14.1 OVERVIEW
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2022–FEBRUARY 2025
14.3 REVENUE ANALYSIS, 2019–2023
14.4 MARKET SHARE ANALYSIS, 2024
14.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024
14.6 BRAND/PRODUCT COMPARISON
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  14.7.1 STARS
  14.7.2 EMERGING LEADERS
  14.7.3 PERVASIVE PLAYERS
  14.7.4 PARTICIPANTS
  14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    14.7.5.1 Company footprint
    14.7.5.2 Region footprint
    14.7.5.3 Vertical footprint
    14.7.5.4 Type footprint
    14.7.5.5 Body part footprint
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  14.8.1 PROGRESSIVE COMPANIES
  14.8.2 RESPONSIVE COMPANIES
  14.8.3 DYNAMIC COMPANIES
  14.8.4 STARTING BLOCKS
  14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
    14.8.5.1 Detailed list of startups/SMEs
    14.8.5.2 Competitive benchmarking of key startups/SMEs
14.9 COMPETITIVE SCENARIO
  14.9.1 PRODUCT LAUNCHES
  14.9.2 DEALS
  14.9.3 EXPANSIONS
  14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

15.1 KEY PLAYERS
  15.1.1 EKSO BIONICS
    15.1.1.1 Business overview
    15.1.1.2 Products/Solutions/Services offered
    15.1.1.3 Recent developments
      15.1.1.3.1 Product launches
      15.1.1.3.2 Deals
      15.1.1.3.3 Other developments
    15.1.1.4 MnM view
      15.1.1.4.1 Key strengths/Right to win
      15.1.1.4.2 Strategic choices
      15.1.1.4.3 Weaknesses and competitive threats
  15.1.2 OTTOBOCK
    15.1.2.1 Business overview
    15.1.2.2 Products/Solutions/Services offered
    15.1.2.3 Recent developments
      15.1.2.3.1 Product launches
    15.1.2.4 MnM view
      15.1.2.4.1 Key strengths/Right to win
      15.1.2.4.2 Strategic choices
      15.1.2.4.3 Weaknesses and competitive threats
  15.1.3 DIH MEDICAL
    15.1.3.1 Business overview
    15.1.3.2 Products/Solutions/Services offered
    15.1.3.3 Recent developments
      15.1.3.3.1 Deals
    15.1.3.4 MnM view
      15.1.3.4.1 Key strengths/Right to win
      15.1.3.4.2 Strategic choices
      15.1.3.4.3 Weaknesses and competitive threats
  15.1.4 COMAU
    15.1.4.1 Business overview
    15.1.4.2 Products/Solutions/Services offered
    15.1.4.3 Recent developments
      15.1.4.3.1 Product launches
    15.1.4.4 MnM view
      15.1.4.4.1 Key strengths/Right to win
      15.1.4.4.2 Strategic choices
      15.1.4.4.3 Weaknesses and competitive threats
  15.1.5 MYOMO INC.
    15.1.5.1 Business overview
    15.1.5.2 Products/Solutions/Services offered
    15.1.5.3 Recent developments
      15.1.5.3.1 Product launches
      15.1.5.3.2 Other developments
    15.1.5.4 MnM view
      15.1.5.4.1 Key strengths/Right to win
      15.1.5.4.2 Strategic choices
      15.1.5.4.3 Weaknesses and competitive threats
  15.1.6 CYBERDYNE INC.
    15.1.6.1 Business overview
    15.1.6.2 Products/Solutions/Services offered
    15.1.6.3 Recent developments
      15.1.6.3.1 Expansions
  15.1.7 LIFEWARD LTD.
    15.1.7.1 Business overview
    15.1.7.2 Products/Solutions/Services offered
    15.1.7.3 Recent developments
      15.1.7.3.1 Deals
  15.1.8 HYUNDAI MOTOR GROUP ROBOTICS LAB.
    15.1.8.1 Business overview
    15.1.8.2 Products/Solutions/Services offered
    15.1.8.3 Recent developments
      15.1.8.3.1 Product launches
      15.1.8.3.2 Deals
  15.1.9 B-TEMIA
    15.1.9.1 Business overview
    15.1.9.2 Products/Solutions/Services offered
  15.1.10 REX BIONICS LTD.
    15.1.10.1 Business overview
    15.1.10.2 Products/Solutions/Services offered
15.2 OTHER PLAYERS
  15.2.1 ABLE HUMAN MOTION
  15.2.2 LAEVO EXOSKELETONS
  15.2.3 GERMAN BIONIC SYSTEMS GMBH
  15.2.4 LEVITATE TECHNOLOGIES, INC.
  15.2.5 FOURIER
  15.2.6 TREXO ROBOTICS
  15.2.7 WANDERCRAFT
  15.2.8 AGADE
  15.2.9 EUROPE TECHNOLOGIES
  15.2.10 GOGOA.EU
  15.2.11 ARCHELIS INC.
  15.2.12 P&S MECHANICS CO., LTD.
  15.2.13 RB3D
  15.2.14 JAPET MEDICAL DEVICES
  15.2.15 PROTESO S.R.L.

16 APPENDIX

16.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.2 CUSTOMIZATION OPTIONS
16.3 RELATED REPORTS
16.4 AUTHOR DETAILS


More Publications